Adverse Drug Events Associated with sitagliptin Versus canagliflozin for the Treatment of Patients with Type 2 Diabetes Mellitus: A Systematic Comparison Through a Meta-Analysis
Crossref DOI link: https://doi.org/10.1007/s13300-018-0481-6
Published Online: 2018-08-09
Published Print: 2018-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Bundhun, Pravesh Kumar
Huang, Feng
Article History
Received: 18 July 2018
First Online: 9 August 2018